AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue growth (%)

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥11.4B
P/E ratio
56.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20250.7-106.20%
Mar 31, 2024-10.6-421.75%
Mar 31, 20233.3-157.47%
Mar 31, 2022-5.8-68.88%
Mar 31, 2021-18.5-1221.82%
Mar 31, 20201.7-211.49%
Mar 31, 2019-1.5-327.69%
Mar 31, 20180.7-120.57%
Mar 31, 2017-3.2-175.96%
Mar 31, 20164.2+50.72%
Mar 31, 20152.8-30.83%
Mar 31, 20144-26.11%
Mar 31, 20135.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)